A Christian charity's urging the international community to work together on the world's first malaria vaccine that could be launched in the next two years.
The jab, which triggers the immune system to fight off the parasite and stop it from multiplying - is the most advanced development of its kind.
Makers, Glaxosmithkline is seeking a licence from medical authorities.
Tearfund's Head of Asia, Sudarshan Sathianathan welcomed the development on Premier's News Hour: